164
Views
35
CrossRef citations to date
0
Altmetric
Review

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies

, , , , , , , , , , , , , & show all
Pages 2593-2610 | Published online: 29 Aug 2017

References

  • VogelmeierCFCrinerGJMartínezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summaryEur Respir J201749170021428182564
  • MurrayCJLopezADMeasuring the global burden of diseaseN Engl J Med201336944845723902484
  • AdeloyeDChuaSLeeCGlobal and regional estimates of COPD prevalence: systematic review and meta-analysisJ Glob Health2015502041526755942
  • RycroftCEHeyesALanzaLBeckerKEpidemiology of chronic obstructive pulmonary disease: a literature reviewInt J Chron Obstruct Pulmon Dis2012745749422927753
  • SorianoJBZielinskiJPriceDScreening for and early detection of chronic obstructive pulmonary diseaseLancet200937472173219716965
  • PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J20052694896816264058
  • GüderGBrennerSAngermannCEGOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-studyRespir Res2012131322309369
  • QuanjerPHStanojevicSColeTJMulti-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equationsEur Respir J2012401324134322743675
  • Vaz FragosoCAMcAvayGVan NessPHPhenotype of normal spirometry in an aging populationAm J Respir Crit Care Med201519281782526114439
  • Vaz FragosoCAMcAvayGVan NessPHPhenotype of spirometric impairment in an aging populationAm J Respir Crit Care Med201619372773526540012
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J20052631933816055882
  • QuanjerPHPrettoJJBrazzaleDJBorosPWGrading the severity of airways obstruction: new wine in new bottlesEur Respir J20144350551223988764
  • O’DonnellDELavenezianaPWebbKNederJAChronic obstructive pulmonary disease: clinical integrative physiologyClin Chest Med201435516924507837
  • ElbehairyAFGuenetteJAFaisalAMechanisms of exertional dyspnoea in symptomatic smokers without COPDEur Respir J20164869470527492828
  • WatzHPittaFRochesterCLAn official European Respiratory Society statement on physical activity in COPDEur Respir J2014441521153725359358
  • RennardSDrummondMBEarly chronic obstructive pulmonary disease: definition, assessment, and preventionLancet20153851778178825943942
  • MartinezFDEarly-life origins of chronic obstructive pulmonary diseaseN Engl J Med201637587187827579637
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
  • CorradoARossiAHow far is real life from COPD therapy guidelines? An Italian observational studyRespir Med201210698999722483189
  • KardosPVogelmeierCWorthHA two-year evaluation of the ‘real life’ impact of COPD on patients in Germany: the DACCORD observational studyRespir Med2017124576428284322
  • PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
  • Rodriguez-RoisinRDrakulovicMRodriguezDARocaJBarberàJAWagnerPDVentilation-perfusion imbalance and chronic obstructive pulmonary disease staging severityJ Appl Physiol (1985)20091061902190819372303
  • CalverleyPMild chronic obstructive pulmonary disease does exist – and affects gas exchange during exerciseAm J Respir Crit Care Med20151911346134726075417
  • HoggJCMacklemPTThurlbeckWMSite and nature of airway obstruction in chronic obstructive lung diseaseN Engl J Med1968278135513605650164
  • HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med20043502645265315215480
  • CosioMGhezzoHHoggJCThe relations between structural changes in small airways and pulmonary-function testsN Engl J Med197829812771281651978
  • BuistASRossBBQuantitative analysis of the alveolar plateau in the diagnosis of early airway obstructionAm Rev Respir Dis1973108107810874746565
  • VerbanckSSchuermansDPaivaMMeysmanMVinckenWSmall airway function improvement after smoking cessation in smokers without airway obstructionAm J Respir Crit Care Med200617485385716799076
  • StănescuDSannaAVeriterCRobertAIdentification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-upChest199811424164259726724
  • HoggJCParéPDHackettTLThe contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary diseasePhysiol Rev20179752955228151425
  • WoodruffPGBarrRGBleeckerEClinical significance of symptoms in smokers with preserved lung functionN Eng J Med201637418111821
  • ReganEALynchDACurran-EverettDClinical and radiologic disease in smokers with normal spirometryJAMA201517515391549
  • FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J1977116451648871704
  • SorianoJBAgustiAInvestigating the natural history of lung function: facts, pitfalls, and opportunitiesChest20091351330134119420200
  • KohansalRMartinez-CamblorPAgustiABuistASManninoDMSorianoJBThe natural history of chronic airflow obstruction revisited: an analysis of the Framingham Offspring cohortAm J Respir Crit Care Med200918031019342411
  • VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med20113651184119221991892
  • McGeachieMJYatesKPZhouXPatterns of growth and decline in lung function in persistent childhood asthmaN Engl J Med20163741842185227168434
  • BurrowsBKnudsonRJLebowitzMDThe relationship of childhood respiratory illness to adult obstructive airway diseaseAm Rev Respir Dis1977115751760857715
  • KerstjensHARijckenBSchoutenJPPostmaDSDecline of FEV1 by age and smoking status: facts, figures, and fallaciesThorax1997528208279371217
  • de MarcoRAccordiniSCerveriIAn international survey of chronic obstructive pulmonary disease in young adults according to GOLD stagesThorax20045912012514760151
  • MiravitllesMSorianoJBGarcia-RioFPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activitiesThorax20096486386819553233
  • ScanlonPDConnettJEWallerLAAltoseMDBaileyWCBuistASSmoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health StudyAm J Respir Crit Care Med200016138139010673175
  • TantucciCModinaDLung function decline in COPDInt J COPD201279599
  • JonesROstremAOptimising pharmacological maintenance treatment for COPD in primary carePrim Care Respir J201120334521103801
  • BridevauxPOGerbaseMWProbst-HenschNMSchindlerCGaspozJMRochatTLong-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPDThorax20086376877418505800
  • KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the Lung Health StudyAm J Respir Crit Care Med200116435836411500333
  • DransfieldMTKunisakiKMStrandMJAcute exacerbations and lung function loss in smokers with and without COPDAm J Respir Crit Care Med201719532433027556408
  • OmachiTAKatzPPYelinEHDepression and health-related quality of life in chronic obstructive pulmonary diseaseAm J Med2009122778.e9e15
  • de TorresJPMarinJMCasanovaCLung cancer in patients with chronic obstructive pulmonary disease: incidence and predicting factorsAm J Respir Crit Care Med201118491391921799072
  • LomasDASilvermanEKEdwardsLDMillerBECoxsonHOTal-SingerREvaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohortThorax2008631058106318757456
  • LomasDASilvermanEKEdwardsLDSerum surfactant protein D is steroid sensitive and associated with exacerbations of COPDEur Respir J2009349510219164344
  • AgustíAEdwardsLDRennardSIPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One20127e3748322624038
  • RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
  • BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD study): a population-based prevalence studyLancet200737074175017765523
  • LamprechtBMcBurnieMAVollmerWMCOPD in never smokers: results from the population-based burden of obstructive lung disease studyChest201113975276320884729
  • LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med201218697598122997207
  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
  • Milic-EmiliJDoes mechanical injury of the peripheral airways play a role in the genesis of COPD in smokers?COPD20041859216997741
  • CosioMGSaettaMAgustiAImmunologic aspects of chronic obstructive pulmonary diseaseN Engl J Med20093602445245419494220
  • HoggJCMcDonoughJESuzukiMSmall airway obstruction in COPD: new insights based on micro-CT imaging and MRI imagingChest20131431436144323648907
  • ChilosiMCarloniARossiAPolettiVPremature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysemaTransl Res201316215617323831269
  • FanerRRojasMMacneeWAgustíAAbnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosisAm J Respir Crit Care Med201218630631322582162
  • MacNeeWAccelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD)Biochem Soc Trans20093781982319614601
  • SvanesCSunyerJPlanaEEarly life origins of chronic obstructive pulmonary diseaseThorax201065142019729360
  • MolfinoNAGenetic predisposition to accelerated decline of lung function in COPDInt J Chron Obstruct Pulmon Dis2007211711918044683
  • SavaleLChaouatABastuji-GarinSShortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200917956657119179485
  • VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201318772873523392440
  • AlderJKGuoNKembouFTelomere length is a determinant of emphysema susceptibilityAm J Respir Crit Care Med201118490491221757622
  • TogoSHolzOLiuXLung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanismsAm J Respir Crit Care Med200817824826018467512
  • KasaharaYTuderRMCoolCDLynchDAFloresSCVoelkelNFEndothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysemaAm J Respir Crit Care Med200116373774411254533
  • HorowitzJCMartinezFJThannickalVJMesenchymal cell fate and phenotypes in the pathogenesis of emphysemaCOPD2009620121019811376
  • PaschalakiKStarkeRDMercadoNHaskardDOBarnesPJRandiAMEndothelial colony forming cells (ECFC) are senescent and dysfunctional in COPD due to reduced sirtuin-1 levelsHeart201197e7
  • GiordanoRJLahdenrantaJZhenLTargeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouseJ Biol Chem2008283294472946018718906
  • LiuHFergussonMMCastilhoRMAugmented Wnt signaling in a mammalian model of accelerated agingScience200731780380617690294
  • MeshorerEGruenbaumYGone with the Wnt/Notch: stem cells in laminopathies, progeria, and agingJ Cell Biol200818191318378774
  • WangRAhmedJWangGDown-regulation of the canonical Wnt β-catenin pathway in the airway epithelium of healthy smokers and smokers with COPDPLoS One20116e1479321490961
  • KneidingerNYildirimAOCallegariJActivation of the WNT/β-catenin pathway attenuates experimental emphysemaAm J Respir Crit Care Med201118372373320889911
  • AmsellemVGary-BoboGMarcosETelomere dysfunction causes sustained inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20111841358136621885626
  • National Institute for Health and Care ExcellenceChronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary CareLondonNICE2010
  • BerendNWoolcockAJMarlinGECorrelation between the function and structure of the lung in smokersAm Rev Respir Dis1979119695705453695
  • HoggJCIdentifying smokers at risk for developing airway obstructionChest1998114355
  • GennimataSAPalamidasAKarakontakiFPathophysiology of evolution of small airways disease to overt COPDCOPD2010726927520673036
  • OxhojHBakeBWilhelmsenLAbility of spirometry, flow-volume curves and the nitrogen closing volume test to detect smokers: a population studyScand J Respir Dis1977588096857303
  • BuistASVollmerWMJohnsonLRMcCamantLEDoes the single-breath N2 test identify the smoker who will develop chronic airflow limitation?Am Rev Respir Dis19881372933013341624
  • VerbanckSSchuermansDMeysmanMPaivaMVinckenWNoninvasive assessment of airway alterations in smokers: the small airways revisitedAm J Respir Crit Care Med200417041441915130906
  • HutcheonMGriffinPLevisonHZamelNVolume of isoflow: a new test in detection of mild abnormalities of lung mechanicsAm Rev Respir Dis19741104584654416882
  • NemeryBMoaveroNEBrasseurLStanescuDCSignificance of small airway tests in middle-aged smokersAm Rev Respir Dis19811242322387283255
  • DeesomchokAWebbKAForkertLLung hyperinflation and its reversibility in patients with airway obstruction of varying severityCOPD2010742843721166631
  • OfirDLavenezianaPWebbKALamYMO’DonnellDEMechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200817762262918006885
  • FrantzSNihlénUDenckerMEngströmGLöfdahlCGWollmerPImpulse oscillometry may be of value in detecting early manifestations of COPDRespir Med20121061116112322613172
  • ElbehairyAFCiavagliaCEWebbKAPulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease: implications for dyspnea and exercise intoleranceAm J Respir Crit Care Med20151911384139425826478
  • GuenetteJAChinRCChengSMechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPDEur Respir J2014441177118725142487
  • HarveyBGStrulovici-BarelYKanerRJRisk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacityEur Respir J2015461589159726541521
  • HarveyBGStrulovici-BarelYKanerRJProgression to COPD in smokers with normal spirometry/low DLCO using different methods to determine normal levelsEur Respir J2016471888188927246083
  • BarberaJARocaJRamirezJWagnerPDUssettiPRodriguez-RoisinRGas exchange during exercise in mild chronic obstructive pulmonary disease: correlation with lung structureAm Rev Respir Dis19911445205251892290
  • LevineGHousleyEMacLeodPMacklemPTGas exchange abnormalities in mild bronchitis and asymptomatic asthmaN Eng J Med197028212771282
  • HueperKVogel-ClaussenJParikhMAPulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema: the MESA COPD studyAm J Respir Crit Care Med201519257058026067761
  • BarrRGBluemkeDAAhmedFSPercent emphysema, airflow obstruction, and impaired left ventricular fillingN Engl J Med201036221722720089972
  • BhattSPSolerXWangXAssociation between functional small airway disease and FEV1 decline in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201619417818426808615
  • CamiciottoliGBigazziFPaolettiMCestelliLLavoriniFPistolesiMPulmonary function and sputum characteristics predict CT phenotype and severity of COPDEur Respir J20134262663523258785
  • SchroederJDMcKenzieASZachJARelationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary diseaseAJR Am J Roentgenol2013201W460W47023971478
  • YuanRHoggJCParéPDPrediction of the rate of decline in FEV1 in smokers using quantitative computed tomographyThorax20096494494919734130
  • VestboJAndersonWCoxonHQEvaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)Eur Respir J20083186987318216052
  • JonesJHZeltJTHiraiDMEmphysema on thoracic CT and exercise ventilatory inefficiency in mild-to-moderate COPDCOPD20171421021827997255
  • LeeJHChoMHMcDonaldMLPhenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGeneRespir Med20141081469148025154699
  • DirksenAWilleMMComputed tomography-based subclassification of chronic obstructive pulmonary diseaseAnn Am Thorac Soc201613Suppl 2S114S11727115944
  • DecramerMRennardSTroostersTCOPD as a lung disease with systemic consequences: clinical impact, mechanisms, and potential for early interventionCOPD2008523525618671149
  • WelteTVogelmeierCPapiACOPD: early diagnosis and treatment to slow disease progressionInt J Clin Pract20156933634925363328
  • Probst-HenschNMCurjuricIPierre-OlivierBLongitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohortThorax20106515015619996350
  • JansonCMarksGBuistSThe impact of COPD on health status: findings from the BOLD studyEur Respir J2013421472148323722617
  • O’ReillyJFWilliamsAEHoltKRiceLDefining COPD exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
  • GreenbergSBAllenMWilsonJAtmarRLRespiratory viral infection in adults with and without chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016216717310903237
  • AgustiACalverleyPACelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
  • Van RemoortelHHornikxMDemeyerHDaily physical activity in subjects with newly diagnosed COPDThorax20136896296323604460
  • Garcia-AymerichJLangePBenetMSchnohrPAntòJMRegular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort studyAm J Respir Crit Care Med200717545846317158282
  • DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet20123791341135122314182
  • Garcia-AymerichJLangePBenetMSchnohrPAntòJMRegular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort studyThorax20066177277816738033
  • WaschkiBKirstenAHolzOPhysical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort studyChest201114033134221273294
  • NgLWMackneyJJenkinsSHillKDoes exercise training change physical activity in people with COPD? A systematic review and meta-analysisChron Respir Dis20129172622194629
  • ManiniTMEverhartJEPatelKVDaily activity energy expenditure and mortality among older adultsJAMA200629617117916835422
  • MiravitllesMSoler-CataluñaJJCalleMSorianoJBTreatment of COPD by clinical phenotypes: putting old evidence into clinical practiceEur Respir J2013411252125623060631
  • MiravitllesMSoler-CataluñaJJCalleMSpanish Guideline for COPD (GesEPOC): update 2014Arch Bronconeumol201450Suppl 1116
  • SubramanianDRGuptaSBurggrafDEmphysema- and airway-dominant COPD phenotypes defined by standardized quantitative computed tomographyEur Respir J2016489210327230444
  • LynchDAAustinJHHoggJCCT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner SocietyRadiology201527719220525961632
  • BettoncelliGBlasiFBrusascoVThe clinical and integrated management of COPDSarcoidosis Vasc Diffuse Lung Dis201431Suppl 132124820963
  • RossiAAisanovZAvdeevSMechanisms, assessment and therapeutic implications of lung hyperinflation in COPDRespir Med201510978580225892293
  • CelliBMacNeeWStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J20042393294615219010
  • O’DonnellDELavenezianaPOraJWebbKALamYMOfirDEvaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPDThorax20096421622319052054
  • CasaburiRMaltaisFPorszaszJEffects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary diseaseAnn Am Thorac Soc2014111351136125289942
  • AnthonisenNRConnettJEMurrayRPSmoking and lung function of Lung Health Study participants after 11 yearsAm J Respir Crit Care Med200216667567912204864
  • WiseRConnettJWeinmannGScanlonPSkeansMEffect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med20003431902190911136260
  • VestboJSørensenTLangePBrixATorrePViskumKLong term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomized controlled trialLancet19993531819182310359405
  • PauwelsRALofdahlCGLatijnenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smokingN Engl J Med19993401948195310379018
  • AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health StudyJAMA1994272149715057966841
  • TashkinDPCelliBSennSA 4–year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • AllisonJPHardyRDonaldsonGCThe presence of chronic mucus hyper secretion across adult life in relation to chronic obstructive pulmonary disease developmentAm J Respir Crit Care Med201619366267226695373
  • Milic-EmiliJTorchioRD’AngeloEClosing volume: a reappraisal (1967–2007)Eur J Appl Physiol20079956758317237952
  • MacklemPTThe therapeutic implications of the pathophysiology of COPDEur Respir J20103567668020190332
  • HughesJMPrideNBIn defence of the carbon monoxide transfer coefficient KCO (TL/V’A)Eur Respir J20011716817411334115
  • HughesJMPrideNBExamination of the carbon monoxide diffusing capacity (DLCO) in relation to its KCO and V’A componentsAm J Respir Crit Care Med201218613213922538804
  • HoeseinFAZanenPvan GinnekenAssociation of the transfer coefficient of the lung carbon monoxide with emphysema progression in male smokersEur Respir J2011381012101821565924
  • BoutouAKShrilkrishnaDTannerRJLung function indices for predicting mortality in COPDEur Respir J20134261662523349449
  • LangePCelliBAugustALung-function trajectories leading to chronic obstructive pulmonary diseaseN Engl J Med201537311112226154786
  • de MarcoRAccordinoSCerveriIIncidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegmAm J Respir Crit Care Med2007175323917008642
  • TorénKOlinAKLindbergAVital capacity and COPD: the Swedish Cardiopulmonary Bioimage Study (SCAPIS)Int J Chron Obstruct Pulm Dis2016111927933
  • GrolMHGerritsenJVonkJMRisk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: a 30-year follow-up studyAm J Respir Crit Care Med19991601830183710588593
  • BerryCEBillheimerDJenkinsICA distinct low lung function trajectory from childhood to the fourth decade of lifeAm J Respir Crit Care Med201619460761227585385
  • AkazawaMHalpernRRiedelAAStanfordRHDalalABlanchetteCMEconomic burden prior to COPD diagnosis: a matched case-control study in the United StatesRespir Med20081021744175218760581
  • MapelDWRobinsonSBDastaniHBShahHPhillipsALLydickEThe direct medical costs of undiagnosed chronic obstructive pulmonary diseaseValue Health20081162863618194402
  • MartinezCHManninoDMJaimesFAUndiagnosed obstructive lung disease in the U.S: associated factors and long-term mortalityAnn Am Thorac Soc2015121788179526524488
  • BednarekMMaciejewskiJWozniakMPrevalence, severity and underdiagnosis of COPD in the primary care settingThorax20086340240718234906
  • LabakiWWMartinezCHHanMKCOPD in 2016: some answers, more questionsLancet2016494194327890500